Venture Capital and the European Biotechnology Industry

W. Bains

$385.95 $346.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

Books that are warehoused locally (in stock at our local suppliers) will normally get to us within 7 to 10 days.

Disruptions to supply chains due to COVID-19 and Brexit have caused significant delays in getting books in from overseas. To find out the anticipated time to get specific titles ordered in for you, please contact us by email or phone:

Email               books@abbeys.com.au

Phone              +61 2 9264 3111

Phone          1800 4 BOOKS (1800 4 26657) if outside Sydney

QTY:

Palgrave Macmillan
20 November 2008

Business strategy; Biotechnology industries

This book opens up the world on private equity investment in one of the hottest industries - Biotechnology. The book describes how Europe has fallen behind the US due to under-investment and bad management by the VCs who control the companies. Detailed analysis shows why it is in VCs' interests to damage the very companies they invest in.

By: W. Bains
Imprint: Palgrave Macmillan
Country of Publication: United Kingdom
Dimensions: Height: 216mm, Width: 140mm, Spine: 14mm
Weight: 420g
ISBN: 9780230217195
ISBN 10: 0230217192
Pages: 220
Publication Date: 20 November 2008
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Introduction: The Facts The Biotechnology Industry and Venture Capital Europe Falls Behind Why Does Europe Do So Poorly? Some Inadequate Explanations Under-investment In European Biotechnology Public Markets and Under-investment VC Management of Companies VC Effects on Business Efficacy Investor Blockade of Business Pomp and Circumstances The Real VC Business Model What to do about it: Government What to do about it: Business References Index

WILLIAM BAINS is an academic and entrepreneur with experience in research, company creation and venture capital. He has founded four biotechnology companies, helped found and finance another ten, and is internationally recognized both as an innovator in biotechnology and a translator of innovation into business. He has written over 100 papers and teaches on innovation and entrepreneurship at Cambridge University, UK.

Reviews for Venture Capital and the European Biotechnology Industry

'With this well-referenced book Dr Bains has filled an important lacuna within the literature on European biotech VC [venture capital] financing with an accessible primer for MBA students particularly those researching biopharma and VC business cases and for students undertaking specialist, industry-focused, post-graduate courses.' Gerhard Symons, Pharmaceutical Executive Europe